top of page

Danish Publicly-traded, Biopharma Company with EU-GACP/GMP facility & strong market position

Danish European Market player seeks partner to takeover and further expand existing facility and operations due to strategy change in their way forward

Listing ID:

11668595469

Licence(s) Held:

EU-GACP and EU-GMP licences

Danish flag with cannabis leaves for an EU GMP cannabis biopharma seeking partner.

Seeking outright divestiture of the licence, lease and going concern business for ~€2 mill (DKK 15 mill)

Listing Details:

  • A fully licensed manufacturing site

  • Holds both EU-GMP and EU-GACP in an totally indoor, leased, 1,200 m2 state-of-the-art production facility utilizing aeroponics-technology and vertical farming located in an industrial area – introducing some of the cleanest world-wide (non-irradiated) flower material to the European market

  • Currently operational and currently utilizing 400 m2production space and 200 m2 for administration and office space

  • Perfect fit for repurposing i.e. facility for import into the European market – due to the 100% indoor facility with EU-GMP approval and fully operational QMS

  • Currently undertaking, cultivation, propagation trimming, drying, bulk packaging, labelling, finished packaging, exports, storage, distribution and export

  • Current production capacity is ~100 kg year/strain and capable to upscale the capacity to produce ~2,200 kg/year of dried cannabis (based on 1-6 strains)

  • At current scale (cultivation), the company expects to hit €270k/yearly (2 MDKK/yearly) and at full commercial scale, it is expected to generate €6.7 million/yearly (50 MDKK/yearly)

  • There is an expansion of 600 m2 possibility to build other production rooms to increase the production capacity to ~2,200 kg/year in the same industrial area – resulting in a highly efficient utilization of square meters

  • Long term lease (10-years rental agreement)

  • More than €7 million spent in the facility

  • Facility comes with all supporting fixtures and equipment

  • Company is seeking buyer for the turnkey project

  • There is an option to acquire the building within the tenor of the rental agreement (real estate valued at ~€910k)

11668595469

Inquiry Form

Thanks for submitting! We have received your message and will get back to you within 24 hours. Until then, you can send an email to info@hydeadvisory.com

Contact-us-deal

NEW CANNABIS BUSINESSES FOR SALE

See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.

Cannabis New/Featured Business Listing - Merger & Acquisition

36324927098

Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner

Cannabis New/Featured Business Listing - Merger & Acquisition

Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential

Cannabis New/Featured Business Listing - Merger & Acquisition

38939049737

4,800 sq ft licensed, micro-cultivation facility in AB for $500k

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a turnkey, fully built, turnkey 4,800 sq ft micro-cultivation facility in AB, offered at a significant discount to replacement cost

Cannabis New/Featured Business Listing - Merger & Acquisition

29345918591

State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub

Cannabis New/Featured Business Listing - Merger & Acquisition

Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.

bottom of page